What is Diversified Healthcare Trust's earnings per share (EPS)?

Diversified Healthcare Trust (DHC) reported diluted earnings per share of -$1.19 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Diversified Healthcare Trust (DHC) Financials

DHC NASDAQ

Trailing 12 months to June 30, 2026

Revenue $1.5B -1.5% YoY

Net Income -$266.0M n/m YoY

EPS (Diluted) -$1.11 n/m YoY

Free Cash Flow -$155.0M n/m YoY

Market Cap $1.9B as of Oct 28, 2026

Price / Sales 1.3x on $1.5B revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 1.2x on $1.6B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 28, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 3, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 3, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DHC SEC filings page.

Diversified Healthcare Trust (DHC) reported $1.5B in revenue over the twelve months to Jun 30, 2026, down 1.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DHC FY2025 2026-10-25

Revenue expanded, but persistent losses and negative free cash flow show operations still do not fund reinvestment.

Operating cash flow moved from $112M in FY2024 to -$19.6M in FY2025, signaling a sharp reversal in cash conversion. That reversal occurred alongside lower capital expenditures of $147M, yet free cash flow was still -$166M.

Total assets fell 15.1% in FY2025 while long-term debt fell 19.9%, indicating balance-sheet contraction was accompanied by debt reduction. Equity also fell 15.0%, so the lower leverage reflects a smaller platform rather than retained capital accumulating.

The net loss narrowed from $370M in FY2024 to $286M in FY2025. Net margin improved 6.2 percentage points, but SG&A rose 71.6%, so reported improvement coexisted with sharply higher overhead.

Financial Health Signals

Financial health score not available

Diversified Healthcare Trust does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

4/7

Diversified Healthcare Trust passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality No Cash Backing

N/A

Diversified Healthcare Trust reported a net loss of $285.9M while operations used $19.6M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$365.4M

YoY-4.5%

QoQ-0.3%

5Y CAGR+1.1%

10Y CAGR+3.4%

Diversified Healthcare Trust generated $365.4M in revenue in Q2 2026. This represents a decrease of 4.5% from the same quarter a year earlier. Against the prior quarter it is down 0.3%.

Net Income

-$37.4M

YoYn/m

QoQn/m

5Y CAGRn/m

Diversified Healthcare Trust reported a net loss of $37.4M in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

-$0.16

YoYn/m

QoQn/m

5Y CAGRn/m

Diversified Healthcare Trust earned -$0.16 per diluted share (EPS) in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$14.2M

YoY-24.6%

QoQn/m

5Y CAGRn/m

10Y CAGR-14.5%

Diversified Healthcare Trust generated $14.2M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 24.6% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt

$116.8M

YoY-17.6%

QoQ-4.1%

5Y CAGR-32.7%

10Y CAGR+16.4%

Diversified Healthcare Trust held $116.8M in cash against $2.4B in long-term debt as of Q2 2026.

Dividends Per Share

$0.01

YoY0.0%

QoQ0.0%

Diversified Healthcare Trust paid $0.01 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

242M

YoY+0.3%

QoQ0.0%

5Y CAGR+0.3%

10Y CAGR+0.2%

Diversified Healthcare Trust had 242M shares outstanding in Q2 2026. This represents an increase of 0.3% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Net Margin

-10.2%

YoY+13.7pp

QoQ+1.6pp

5Y change-0.4pp

10Y change-25.3pp

Diversified Healthcare Trust's net profit margin was -10.2% in Q2 2026, showing the share of revenue converted to profit. This is up 13.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.6 percentage points.

Return on Equity

-2.4%

YoY+2.6pp

QoQ+0.3pp

5Y change-0.9pp

10Y change-3.6pp

Diversified Healthcare Trust's quarterly ROE was -2.4% in Q2 2026: one quarter's net income over shareholder equity, not annualized. This is up 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$50K

YoY-51.5%

QoQ-43.2%

5Y CAGR-3.3%

Diversified Healthcare Trust spent $50K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 51.5% from the same quarter a year earlier. Against the prior quarter it is down 43.2%.

Capital Expenditures

$24.2M

YoY-29.2%

QoQ-31.2%

5Y CAGR-9.3%

10Y CAGR-0.5%

Diversified Healthcare Trust invested $24.2M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 29.2% from the same quarter a year earlier. Against the prior quarter it is down 31.2%.

R&D Spending

Not reported for Q2 2026.

DHC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DHC quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$1.5B	$1.5B+2.8%	$1.5B+6.0%	$1.4B+9.9%	$1.3B-7.2%	$1.4B-15.2%	$1.6B+56.9%	$1.0B-6.9%	$1.1B+3.9%	$1.1B+1.6%	$1.1B+5.9%	$998.8M+18.2%	$844.9M+11.0%	$761.4M+19.9%	$634.8M+41.1%	$450.0M
SG&A Expenses	$58.7M	$45.5M+71.6%	$26.5M+1.5%	$26.1M-1.1%	$26.4M-22.4%	$34.1M+11.4%	$30.6M-17.4%	$37.0M-56.9%	$85.9M-17.2%	$103.7M+122.7%	$46.6M+8.7%	$42.8M+10.0%	$38.9M+19.3%	$32.7M+3.6%	$31.5M+21.0%	$26.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$275.2M-9.2%	$303.1M-3.3%	$313.5M+7.6%	$291.4M+10.2%	$264.5M+4.1%	$254.1M+11.7%	$227.5M
EBITDA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$552.1M-6.6%	$590.9M+3.4%	$571.3M+19.8%	$476.8M+14.2%	$417.5M+6.2%	$393.1M+15.4%	$340.8M
Interest Expense	$169.9M	$204.5M-13.1%	$235.2M+22.7%	$191.8M-8.4%	$209.4M-18.1%	$255.8M+26.9%	$201.5M+11.9%	$180.1M+0.5%	$179.3M+8.6%	$165.0M-1.5%	$167.6M+11.1%	$150.9M+11.7%	$135.1M+14.7%	$117.8M+0.5%	$117.2M+19.3%	$98.3M
Income Tax	$2.8M	$1.7M+273.2%	$467K+4.9%	$445K-37.3%	$710K-50.3%	$1.4M+14.4%	$1.3M+186.7%	$436K-8.4%	$476K+4.8%	$454K+7.1%	$424K-26.1%	$574K-0.3%	$576K-4.0%	$600K+60.0%	$375K+20.2%	$312K
Net Income	-$266.0M	-$285.9Mn/m	-$370.3Mn/m	-$293.6Mn/m	-$15.8M-109.0%	$174.5Mn/m	-$139.5Mn/m	-$88.2M-130.8%	$286.9M+94.3%	$147.6M+4.5%	$141.3M+14.0%	$124.0M-21.9%	$158.6M+4.9%	$151.2M+11.2%	$135.9M-10.3%	$151.4M
EPS (Basic)	N/A	-$1.19n/m	-$1.55n/m	-$1.23n/m	-$0.07-109.6%	$0.73n/m	-$0.59n/m	-$0.37-130.6%	$1.21+95.2%	$0.62+3.3%	$0.60+13.2%	$0.53-33.8%	$0.80-1.2%	$0.81+1.3%	$0.80-20.8%	$1.01
EPS (Diluted)	-$1.11	-$1.19n/m	-$1.55n/m	-$1.23n/m	-$0.07-109.6%	$0.73n/m	-$0.59n/m	-$0.37-130.6%	$1.21+95.2%	$0.62+3.3%	$0.60+13.2%	$0.53-33.8%	$0.80-1.2%	$0.81+1.3%	$0.80-20.8%	$1.01
Diluted Shares (Avg)	N/A	240M+0.3%	240M+0.3%	239M+0.2%	238M+0.1%	238M+0.1%	238M+0.1%	238M0.0%	238M0.0%	237M0.0%	237M+1.9%	233M+17.1%	199M+6.1%	187M+10.5%	170M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$365.4M-4.5%	$366.5M-5.3%	$379.6M0.0%	$388.7M+4.0%	$382.7M+3.0%	$386.9M+4.3%	$379.6M+5.0%	$373.6M+4.8%
SG&A Expenses	$19.3M+73.0%	$14.0M+56.0%	$12.5Mn/m	$12.8M-8.2%	$11.2M+78.5%	$9.0M+18.9%	-$1.2M-120.7%	$13.9M+100.4%
Interest Expense	$37.1M-27.2%	$37.0M-35.9%	$46.9M-21.3%	$48.9M-17.8%	$50.9M-13.2%	$57.8M+0.4%	$59.5M+21.8%	$59.4M+24.5%
Income Tax	$1.3M+53.9%	$622K+1169.4%	$514Kn/m	$337K+127.7%	$843K+395.9%	$49K-73.8%	-$38K-157.6%	$148K-21.7%
Net Income	-$37.4Mn/m	-$43.3Mn/m	-$21.2Mn/m	-$164.0Mn/m	-$91.6Mn/m	-$9.0Mn/m	-$87.4Mn/m	-$98.7Mn/m
EPS (Basic)	-$0.16n/m	-$0.18n/m	-$0.09n/m	-$0.68n/m	-$0.38n/m	-$0.04n/m	-$0.37n/m	-$0.41n/m
EPS (Diluted)	-$0.16n/m	-$0.18n/m	-$0.09n/m	-$0.68n/m	-$0.38n/m	-$0.04n/m	-$0.37n/m	-$0.41n/m
Diluted Shares (Avg)	241M+0.3%	241M+0.3%	N/A	240M+0.3%	240M+0.3%	240M+0.3%	N/A	240M+0.3%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

DHC Balance Sheet

DHC quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$4.4B-15.1%	$5.1B-5.7%	$5.4B-9.3%	$6.0B-9.4%	$6.6B+2.3%	$6.5B-2.7%	$6.7B-7.1%	$7.2B-1.8%	$7.3B+0.9%	$7.2B+0.9%	$7.2B+20.5%	$5.9B+24.7%	$4.8B+0.4%	$4.7B+8.3%	$4.4B
Cash & Equivalents	$105.4M-27.1%	$144.6M-41.2%	$245.9M-62.6%	$658.1M+3.7%	$634.8M+753.1%	$74.4M+99.2%	$37.4M-32.0%	$55.0M+76.0%	$31.2M-1.6%	$31.7M-15.7%	$37.7M+36.5%	$27.6M-29.7%	$39.2M-7.4%	$42.4M+79.9%	$23.6M
Total Liabilities	$2.7B-15.2%	$3.2B+2.2%	$3.1B-7.6%	$3.4B-15.1%	$4.0B+2.7%	$3.9B+2.1%	$3.8B-5.1%	$4.0B-0.9%	$4.0B-0.3%	$4.0B+6.0%	$3.8B+26.0%	$3.0B+51.7%	$2.0B-5.4%	$2.1B+10.0%	$1.9B
Long-Term Debt	$2.4B-19.9%	$3.1B	N/A	N/A	N/A	N/A	N/A	$3.7B	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.7B-15.0%	$2.0B-16.2%	$2.3B-11.4%	$2.6B-0.9%	$2.7B+6.7%	$2.5B-8.8%	$2.7B-9.5%	$3.0B-2.6%	$3.1B-3.0%	$3.2B-4.8%	$3.4B+13.8%	$3.0B+6.3%	$2.8B+4.9%	$2.6B+7.0%	$2.5B
Retained Earnings	$1.1B-20.3%	$1.4B-20.8%	$1.8B-14.2%	$2.1B-0.8%	$2.1B+9.1%	$1.9B-6.8%	$2.1B-4.1%	$2.1B+21.2%	$1.8B+9.1%	$1.6B+9.6%	$1.5B+9.2%	$1.4B+13.3%	$1.2B+14.5%	$1.0B+15.0%	$907.9M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$4.2B-10.9%	$4.3B-14.6%	$4.4B-15.1%	$4.7B-11.4%	$4.8B-10.8%	$5.0B-6.6%	$5.1B-5.7%	$5.3B-4.4%
Cash & Equivalents	$116.8M-17.6%	$121.8M-59.8%	$105.4M-27.1%	$201.4M-21.5%	$141.8M-46.6%	$302.6M+46.1%	$144.6M-41.2%	$256.5M-7.8%
Total Liabilities	$2.7B-8.5%	$2.6B-13.1%	$2.7B-15.2%	$3.0B-7.5%	$2.9B-8.9%	$3.0B-1.7%	$3.2B+2.2%	$3.2B+4.8%
Long-Term Debt	$2.4B	$2.4B	$2.4B-19.9%	N/A	N/A	N/A	$3.1B	N/A
Total Equity	$1.6B-14.7%	$1.6B-16.8%	$1.7B-15.0%	$1.7B-17.6%	$1.9B-13.7%	$1.9B-13.4%	$2.0B-16.2%	$2.0B-16.1%
Retained Earnings	$1.0B-20.3%	$1.1B-22.9%	$1.1B-20.3%	$1.1B-23.5%	$1.3B-18.0%	$1.4B-17.3%	$1.4B-20.8%	$1.5B-20.5%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill, Current Liabilities, Non-Current Liabilities.

DHC Cash Flow Statement

DHC quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	-$22.7M	-$19.6M-117.5%	$112.2M+970.5%	$10.5Mn/m	-$40.4Mn/m	-$63.3M-139.9%	$158.5M-40.4%	$265.8M-32.3%	$392.8M-6.3%	$419.3M-1.2%	$424.5M+4.7%	$405.5M+15.6%	$350.9M+14.4%	$306.7M+8.3%	$283.3M+11.4%	$254.2M
Depreciation & Amortization	N/A	$261.9M-8.1%	$285.0M+0.3%	$284.1M+18.7%	$239.3M-11.7%	$271.1M+0.4%	$270.1M-6.5%	$289.0M+1.0%	$286.2M+3.4%	$276.9M-3.8%	$287.8M+11.7%	$257.8M+39.0%	$185.4M+21.2%	$153.0M+10.1%	$139.0M+22.8%	$113.3M
Stock-Based Compensation	N/A	$3.4M+24.2%	$2.7M+49.3%	$1.8M+6.2%	$1.7M-11.6%	$2.0M+25.0%	$1.6M+13.0%	$1.4M-37.6%	$2.2M+3.2%	$2.2M-1.8%	$2.2M+59.9%	$1.4M-28.3%	$1.9M-2.4%	$2.0M+7.3%	$1.8M+10.1%	$1.7M
Capital Expenditures	$132.3M	$146.8M-27.2%	$201.7M-14.2%	$235.0M-21.5%	$299.4M+31.5%	$227.6M+22.6%	$185.6M-16.6%	$222.4M+114.3%	$103.8M-11.4%	$117.2M+17.6%	$99.7M+41.5%	$70.4M+8.8%	$64.8M+23.9%	$52.3M+4.3%	$50.1M+27.5%	$39.3M
Free Cash Flow	-$155.0M	-$166.4Mn/m	-$89.5Mn/m	-$224.5Mn/m	-$339.7Mn/m	-$290.9Mn/m	-$27.0M-162.3%	$43.4M-85.0%	$289.0M-4.3%	$302.1M-7.0%	$324.8M-3.1%	$335.1M+17.1%	$286.1M+12.5%	$254.4M+9.1%	$233.2M+8.5%	$214.9M
Investing Cash Flow	$188.4M	$483.6Mn/m	-$187.0Mn/m	-$202.1M-152.1%	$387.7M+59.8%	$242.7Mn/m	-$40.4M-146.9%	$86.2M-13.0%	$99.1Mn/m	-$221.4Mn/m	-$292.9Mn/m	-$1.2Bn/m	-$1.3Bn/m	-$153.0Mn/m	-$327.9Mn/m	-$840.8M
Financing Cash Flow	-$178.1M	-$492.0Mn/m	-$22.3Mn/m	-$249.7Mn/m	-$676.0M-190.5%	$746.7Mn/m	-$79.5Mn/m	-$369.9Mn/m	-$469.2Mn/m	-$186.1Mn/m	-$139.8M-117.1%	$817.6M-9.3%	$901.5Mn/m	-$156.8M-347.4%	$63.4M-89.4%	$599.2M
Dividends Paid	$9.7M	$9.7M+0.4%	$9.6M+0.3%	$9.6M+0.3%	$9.6M+0.3%	$9.5M-77.7%	$42.8M-78.6%	$199.7M-46.1%	$370.7M0.0%	$370.6M0.0%	$370.5M+4.0%	$356.4M+16.6%	$305.8M+5.8%	$288.9M+11.3%	$259.5M+16.1%	$223.5M
Share Buybacks	$1.2M	$1.1M+26.7%	$904K+130.0%	$393K+129.8%	$171K-55.4%	$383K+124.0%	$171K-42.8%	$299K-27.3%	$411K+20.5%	$341K-24.6%	$452K+113.2%	$212Kn/m	$0	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$38.4M-27.6%	$8.3Mn/m	-$20.1M-210.5%	-$49.3M-333.2%	$53.0M+19.7%	-$3.2M-111.3%	$18.2Mn/m	$21.1Mn/m
Depreciation & Amortization	$62.5M-5.6%	$62.9M-7.9%	$62.0M-20.0%	$65.3M-5.3%	$66.3M-3.1%	$68.3M-2.6%	$77.5M-7.3%	$69.0M+2.6%
Capital Expenditures	$24.2M-29.2%	$35.2M-11.3%	$32.4M-51.4%	$40.6M-14.2%	$34.2M-16.6%	$39.6M-15.1%	$66.7M+0.2%	$47.2M-21.9%
Free Cash Flow	$14.2M-24.6%	-$26.8Mn/m	-$52.5Mn/m	-$89.8Mn/m	$18.8M+471.7%	-$42.9Mn/m	-$48.5Mn/m	-$26.1Mn/m
Investing Cash Flow	-$38.7Mn/m	$13.6M-95.3%	$207.4Mn/m	$6.1Mn/m	-$21.1Mn/m	$291.1Mn/m	-$66.1Mn/m	-$25.2Mn/m
Financing Cash Flow	-$3.3Mn/m	-$3.9Mn/m	-$275.1Mn/m	$104.2Mn/m	-$190.0M-448.8%	-$131.0Mn/m	-$63.6M-341.6%	-$4.6Mn/m
Dividends Paid	$2.4M+0.3%	$2.4M+0.3%	$2.4M+0.3%	$2.4M+0.3%	$2.4M+0.4%	$2.4M+0.4%	$2.4M+0.4%	$2.4M+0.3%
Share Buybacks	$50K-51.5%	$88K+1366.7%	$82K+4000.0%	$954K+22.2%	$103K+139.5%	$6K-92.3%	$2K-71.4%	$781K+121.2%

Not reported in any period shown, so not listed: Stock-Based Compensation.

DHC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DHC quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	25.6%-3.0pp	28.6%-2.7pp	31.4%-3.1pp	34.5%-0.3pp	34.7%-5.3pp	40.0%-10.5pp	50.6%
Net Margin	-18.6%+6.2pp	-24.8%-3.9pp	-20.8%-19.6pp	-1.2%-13.9pp	12.6%+21.2pp	-8.5%-0.1pp	-8.5%-34.2pp	25.7%+11.9pp	13.7%+0.4pp	13.4%+0.9pp	12.4%-6.4pp	18.8%-1.1pp	19.9%-1.6pp	21.4%-12.2pp	33.7%
Return on Equity	-17.2%+1.7pp	-18.9%-6.3pp	-12.6%-12.0pp	-0.6%-7.2pp	6.6%+12.1pp	-5.6%-2.4pp	-3.2%-12.7pp	9.5%+4.7pp	4.8%+0.3pp	4.4%+0.7pp	3.7%-1.7pp	5.4%-0.1pp	5.4%+0.3pp	5.1%-1.0pp	6.1%
Return on Assets	-6.6%+0.6pp	-7.2%-1.8pp	-5.4%-5.1pp	-0.3%-2.9pp	2.6%+4.8pp	-2.1%-0.8pp	-1.3%-5.3pp	4.0%+2.0pp	2.0%+0.1pp	1.9%+0.2pp	1.7%-0.9pp	2.7%-0.5pp	3.2%+0.3pp	2.9%-0.6pp	3.5%
Debt-to-Equity	1.47-0.1x	1.56	N/A	N/A	N/A	N/A	N/A	1.22	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Liabilities-to-Equity	1.620.0x	1.62+0.3x	1.33+0.1x	1.27-0.2x	1.49-0.1x	1.55+0.2x	1.38+0.1x	1.320.0x	1.290.0x	1.26+0.1x	1.13+0.1x	1.02+0.3x	0.72-0.1x	0.790.0x	0.77
Asset Turnover	0.35+0.1x	0.290.0x	0.260.0x	0.210.0x	0.210.0x	0.25+0.1x	0.160.0x	0.160.0x	0.150.0x	0.150.0x	0.140.0x	0.140.0x	0.160.0x	0.130.0x	0.10
FCF Margin	-10.8%-4.8pp	-6.0%+9.9pp	-15.9%+10.5pp	-26.5%-5.4pp	-21.0%-19.4pp	-1.7%-5.8pp	4.2%-21.7pp	25.9%-2.2pp	28.1%-2.6pp	30.7%-2.9pp	33.6%-0.3pp	33.9%+0.5pp	33.4%-3.3pp	36.7%-11.0pp	47.8%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Net Margin	-10.2%+13.7pp	-11.8%-9.5pp	-5.6%+17.4pp	-42.2%-15.8pp	-23.9%+2.4pp	-2.3%+20.9pp	-23.0%+5.3pp	-26.4%-8.0pp
Return on Equity	-2.4%+2.6pp	-2.7%-2.2pp	-1.3%+3.2pp	-9.7%-4.9pp	-4.9%-0.4pp	-0.5%+3.4pp	-4.5%-0.1pp	-4.8%-2.1pp
Return on Assets	-0.9%+1.1pp	-1.0%-0.8pp	-0.5%+1.2pp	-3.5%-1.6pp	-1.9%-0.1pp	-0.2%+1.4pp	-1.7%+0.2pp	-1.9%-0.7pp
Debt-to-Equity	1.54	1.51	1.47-0.1x	N/A	N/A	N/A	1.56	N/A
Liabilities-to-Equity	1.68+0.1x	1.63+0.1x	1.620.0x	1.77+0.2x	1.56+0.1x	1.56+0.2x	1.62+0.3x	1.58+0.3x
Asset Turnover	0.090.0x	0.090.0x	0.090.0x	0.080.0x	0.080.0x	0.080.0x	0.070.0x	0.070.0x
FCF Margin	3.9%-1.0pp	-7.3%+3.8pp	-13.8%-1.0pp	-23.1%-16.1pp	4.9%+4.0pp	-11.1%-6.2pp	-12.8%+7.6pp	-7.0%+13.9pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Diversified Healthcare Trust DHC	FY2025	$1.5B	-$285.9M	-18.6%	$1.9B	—
LTC Properties, Inc. LTC	FY2025	$262.9M	$118.0M	44.9%	$2.3B	56/100
Strawberry Fields REIT, Inc. STRW	FY2025	$155.0M	$7.6M	4.9%	$175.7M	64/100
Universal Health Realty Income Trust UHT	FY2025	$99.2M	$17.6M	17.8%	$510.9M	52/100

Where Diversified Healthcare Trust Ranks

Frequently Asked Questions

What is Diversified Healthcare Trust's annual revenue?

Diversified Healthcare Trust (DHC) reported $1.5B in total revenue for fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Diversified Healthcare Trust's revenue growing?

Diversified Healthcare Trust (DHC) revenue grew by 2.8% year-over-year, from $1.5B to $1.5B in fiscal year 2025.

Is Diversified Healthcare Trust profitable?

No, Diversified Healthcare Trust (DHC) reported a net loss of $266.0M over the trailing 12 months to June 30, 2026. In fiscal year 2025 it reported a net loss of $285.9M, with a net profit margin of -18.6%.

How much debt does Diversified Healthcare Trust have?

As of fiscal year 2025, Diversified Healthcare Trust (DHC) had $105.4M in cash and equivalents against $2.4B in long-term debt.

What is Diversified Healthcare Trust's net profit margin?

Diversified Healthcare Trust (DHC) had a net profit margin of -18.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Diversified Healthcare Trust pay dividends?

Yes, Diversified Healthcare Trust (DHC) paid $0.04 per share in dividends during fiscal year 2025.

What is Diversified Healthcare Trust's return on equity (ROE)?

Diversified Healthcare Trust (DHC) has a return on equity of -17.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Diversified Healthcare Trust's free cash flow?

Diversified Healthcare Trust (DHC) recorded an outflow of $166.4M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Diversified Healthcare Trust's operating cash flow?

Diversified Healthcare Trust (DHC) recorded an outflow of $19.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Diversified Healthcare Trust's total assets?

Diversified Healthcare Trust (DHC) had $4.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Diversified Healthcare Trust's capital expenditures?

Diversified Healthcare Trust (DHC) invested $146.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Diversified Healthcare Trust buy back shares?

Yes, Diversified Healthcare Trust (DHC) spent $1.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Diversified Healthcare Trust have outstanding?

Diversified Healthcare Trust (DHC) had 242M shares outstanding as of fiscal year 2025.

What is Diversified Healthcare Trust's debt-to-equity ratio?

Diversified Healthcare Trust (DHC) had a debt-to-equity ratio of 1.47 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

What is Diversified Healthcare Trust's liabilities-to-equity ratio?

Diversified Healthcare Trust (DHC) had a liabilities-to-equity ratio of 1.62 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

What is Diversified Healthcare Trust's return on assets (ROA)?

Diversified Healthcare Trust (DHC) had a return on assets of -6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Diversified Healthcare Trust's P/E ratio?

Diversified Healthcare Trust (DHC) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $1.9B as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Diversified Healthcare Trust's price-to-sales ratio?

Diversified Healthcare Trust (DHC) trades at 1.3x sales, its market capitalization divided by $1.5B revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.9B as of Oct 28, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Diversified Healthcare Trust's Piotroski F-Score?

Diversified Healthcare Trust (DHC) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Diversified Healthcare Trust's earnings high quality?

Diversified Healthcare Trust (DHC) reported a net loss of $285.9M while operations used $19.6M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.